SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-24-008952
Filing Date
2024-03-22
Accepted
2024-03-22 16:21:16
Documents
1
Period of Report
2024-03-05

Document Format Files

Seq Description Document Type Size
1 form4a-03222024_080309.html 4/A  
1 form4a-03222024_080309.xml 4/A 4395
  Complete submission text file 0001415889-24-008952.txt   5782
Mailing Address
Business Address
ALBINI EDWARD C (Reporting) CIK: 0001240014 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38662 | Film No.: 24775532

Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)